Results 81 to 90 of about 28,266 (219)

Thrombophilia testing in the inpatient setting: impact of an educational intervention

BMC Medical Informatics and Decision Making, 2019
Background Thrombophilia testing is frequently ordered in the inpatient setting despite its limited impact on clinical decision-making and unreliable results in the setting of acute thrombosis or ongoing anticoagulation. We sought to determine the effect
Henry Kwang, Eric Mou, Ilana Richman, Andre Kumar, Caroline Berube, Rajani Kaimal, Neera Ahuja, Stephanie Harman, Tyler Johnson, Neil Shah, Ronald Witteles, Robert Harrington, Lisa Shieh, Jason Hom   +13 more
doaj   +1 more source

Is Thrombophilia Testing Useful?

, 2011
Thrombophilia is found in many patients presenting with venous thromboembolism (VTE). However, whether the results of such tests help in the clinical management of such patients has not been determined. Thrombophilia testing in asymptomatic relatives may
Saskia Middeldorp
core   +1 more source

Serum markers thrombophilia in pregnant women with Systemic Lupus Erythematosus

Revista Brasileira de Saúde Materno Infantil
Objectives: to determine the frequency of serum markers for hereditary and acquired thrombophilia and their association with pregnancy in women with Systemic Lupus Erythematosus (SLE).
Vanessa Marcon de Oliveira, Ernesto Antonio Figueiró-Filho, Cristiane Munaretto Ferreira, Erica Freire de Vasconcelos Pereira   +3 more
doaj   +1 more source

Interpretation of Hereditary Thrombophilia Test Results and Anticoagulation Decisions Across Specialties: A Scenario-Based Physician Survey

Cerrahpaşa Medical Journal
Objective: This study aimed to evaluate specialty-based differences in the interpretation of thrombophilia panel results and their influence on anticoagulation-related decisions.
İpek Çalık, Mehmet Oruç, Ayşe Bahadır, Gözde Özsoy Şen, Şevket Tuna Türkkolu, Gizem Gürsoy, Melike Makul Öner, Verda Alpay, İstemi Serin   +8 more
doaj   +1 more source

Clinical Outcomes of Efanesoctocog Alfa Prophylaxis in Children With Severe Haemophilia A: Interim Data From XTEND‐ed

Haemophilia, EarlyView.
Lynn Malec, Beatrice Nolan, Anthony K C Chan, Manuela Albisetti, Sheng‐Chieh Chou, Bulent Zulfikar, Mindy Simpson, Liqi Feng, Helena Palmborg, Graham Neill, Lydia Abad‐Franch, Sriya Gunawardena, Karin Fijnvandraat   +12 more
wiley   +1 more source

Thrombophilia [PDF]

Clinical and Applied Thrombosis/Hemostasis, 2013
A. Nicolaides, J. Fareed, A. K. Kakkar, A. J. Comerota, S. Z. Goldhaber, R. Hull, K. Myers, M. Samama, J. Fletcher, E. Kalodiki, D. Bergqvist, J. Bonnar, J. A. Caprini, C. Carter, J. Conard, B. Eklof, I. Elalamy, G. Gerotziafas, G. Geroulakos, A. Giannoukas, I. Greer, M. Griffin, S. Kakkos, M. R. Lassen, G. D. O. Lowe, A. Markel, P. Prandoni, G. Raskob, A. C. Spyropoulos, A. G. Turpie, J. M. Walenga, D. Warwick   +31 more
openaire   +2 more sources

Hereditary Thrombophilia and Pregnancy: Thrombotic Risk and Pregnancy Outcome [PDF]

, 2012
Thromboembolic disease and obstetric complications related to ischemia of the placenta are currently the major causes of maternal mortality and morbidity.
Fonseca, Ana Glória Rodrigues Sanches da
core  

PO008 | HISTORY OF CANCER IN VTE PATIENTS WITH AND WITHOUT HEREDITARY THROMBOPHILIA: A SINGLE CENTER COHORT STUDY

Bleeding, Thrombosis and Vascular Biology
Background and Aims. Hypercoagulability is a well-recognized feature of cancer and may play a role in tumor development and progression. Hereditary thrombophilia confers a lifelong predisposition to thrombosis, yet its relationship with cancer risk ...
Angela Napolitano
doaj  

Is thrombophilia a risk factor for placenta-mediated pregnancy complications?

, 2012
PURPOSE: To determine if thrombophilia is a risk factor for placenta-mediated pregnancy complications (PMPC) (i.e., preeclampsia, intrauterine growth restriction (IUGR), placental abruption, intrauterine fetal death and recurrent pregnancy loss).METHODS:
Hoffmann, Elise, Lyndrup, Jens, Hedlund, Elisabeth, Perin, Trine   +3 more
core   +1 more source

THROMBOPHILIA MARKERS AT WOMEN PATIENTS WITH HISTORY OF FETO-MATERNAL DISEASE AND THROMBOPHILIA [PDF]

, 2016
The level of molecular markers of a thrombophilia (TAT, D-dimer) and platelet aggregate formation activity allows to estimate risk of obstetric complications at patients with the complicated pregnancy in the anamnesis and a thrombophilia.
M. D. Andreeva
core   +1 more source